These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28034792)

  • 1. Glutathione in the human brain: Review of its roles and measurement by magnetic resonance spectroscopy.
    Rae CD; Williams SR
    Anal Biochem; 2017 Jul; 529():127-143. PubMed ID: 28034792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of magnetic resonance spectroscopy in cerebral glutathione quantification for youth mental health: A systematic review.
    Fisher E; Gillam J; Upthegrove R; Aldred S; Wood SJ
    Early Interv Psychiatry; 2020 Apr; 14(2):147-162. PubMed ID: 31148383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo.
    Choi IY; Lee P
    NMR Biomed; 2013 Jan; 26(1):28-34. PubMed ID: 22730142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance spectroscopy of the brain.
    Currie S; Hadjivassiliou M; Craven IJ; Wilkinson ID; Griffiths PD; Hoggard N
    Postgrad Med J; 2013 Feb; 89(1048):94-106. PubMed ID: 23014671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain oxidative stress: detection and mapping of anti-oxidant marker 'Glutathione' in different brain regions of healthy male/female, MCI and Alzheimer patients using non-invasive magnetic resonance spectroscopy.
    Mandal PK; Tripathi M; Sugunan S
    Biochem Biophys Res Commun; 2012 Jan; 417(1):43-8. PubMed ID: 22120629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain glutathione levels--a novel biomarker for mild cognitive impairment and Alzheimer's disease.
    Mandal PK; Saharan S; Tripathi M; Murari G
    Biol Psychiatry; 2015 Nov; 78(10):702-10. PubMed ID: 26003861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo assessment of neurotransmitters and modulators with magnetic resonance spectroscopy: application to schizophrenia.
    Wijtenburg SA; Yang S; Fischer BA; Rowland LM
    Neurosci Biobehav Rev; 2015 Apr; 51():276-95. PubMed ID: 25614132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain biochemistry using magnetic resonance spectroscopy: relevance to psychiatric illness in the elderly.
    Moore CM; Frederick BB; Renshaw PF
    J Geriatr Psychiatry Neurol; 1999; 12(3):107-17. PubMed ID: 10593699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance spectroscopy study of the antioxidant defense system in schizophrenia.
    Matsuzawa D; Hashimoto K
    Antioxid Redox Signal; 2011 Oct; 15(7):2057-65. PubMed ID: 20712400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of elevated glutathione in meningiomas by quantitative in vivo 1H MRS.
    Opstad KS; Provencher SW; Bell BA; Griffiths JR; Howe FA
    Magn Reson Med; 2003 Apr; 49(4):632-7. PubMed ID: 12652533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional magnetic resonance imaging of cholinergic modulation in mild cognitive impairment.
    Dickerson BC
    Curr Opin Psychiatry; 2006 May; 19(3):299-306. PubMed ID: 16612217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of reduced and oxidized glutathione to signals detected by magnetic resonance spectroscopy as indicators of local brain redox state.
    Satoh T; Yoshioka Y
    Neurosci Res; 2006 May; 55(1):34-9. PubMed ID: 16503064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glutathione relates to neuropsychological functioning in mild cognitive impairment.
    Duffy SL; Lagopoulos J; Hickie IB; Diamond K; Graeber MB; Lewis SJ; Naismith SL
    Alzheimers Dement; 2014 Jan; 10(1):67-75. PubMed ID: 23688577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatine in the central nervous system: From magnetic resonance spectroscopy to creatine deficiencies.
    Rackayova V; Cudalbu C; Pouwels PJW; Braissant O
    Anal Biochem; 2017 Jul; 529():144-157. PubMed ID: 27840053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of magnetic resonance spectroscopy in the study of brain disease].
    Pérez-Gómez M; Junqué C; Mercader JM; Berenguer J
    Rev Neurol; 2000 Jan 16-31; 30(2):155-60. PubMed ID: 10730323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metabolite alterations in infants born preterm with intrauterine growth restriction: association with structural changes and neurodevelopmental outcome.
    Simões RV; Muñoz-Moreno E; Cruz-Lemini M; Eixarch E; Bargalló N; Sanz-Cortés M; Gratacós E
    Am J Obstet Gynecol; 2017 Jan; 216(1):62.e1-62.e14. PubMed ID: 27667762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRS studies of neuroenergetics and glutamate/glutamine exchange in rats: Extensions to hyperammonemic models.
    Lanz B; Rackayova V; Braissant O; Cudalbu C
    Anal Biochem; 2017 Jul; 529():245-269. PubMed ID: 28017739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The partial volume effect in the quantification of 1H magnetic resonance spectroscopy in Alzheimer's disease and aging.
    Mato Abad V; Quirós A; García-Álvarez R; Loureiro JP; Alvarez-Linera J; Frank A; Hernández-Tamames JA
    J Alzheimers Dis; 2014; 42(3):801-11. PubMed ID: 24927708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.